Trailing-twelve-month (TTM) revenue is $10.84 Million with a year-over-year growth of +53.42%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $2,523,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-10 |
| Q4 FY2025Period ended 2025-12-31 | $3,149,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-18 |
| Q1 FY2026Period ended 2026-03-31 | $3,398,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $1,771,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-14 |
| TTM revenue | $10,841,000 |
Current P/S: $24,599,843 market capitalization ÷ $10,841,000 TTM revenue = 2.27x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.77M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:42:31.537Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2022-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20152015-12-31 · USD | FY20222022-12-31 · USD |
|---|---|---|
| Cguard | $703,000 | N/A |
| CGuard EPS | N/A | $5M |
| MGuard | $2M | N/A |
| MGuard Prime EPS | N/A | $48,000 |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20142014-12-31 · USD | FY20152015-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Belarus | $285,000 | $226,000 | N/A | N/A | N/A | N/A |
| Brazil | N/A | $238,000 | N/A |
$10.84M
$10.84 Million
+53.42%
vs. $7.07M a year ago (TTM)
+27.79%
5 Year compound annual growth rate
1 Year
+53.42%
3 Year
+26.58%
5 Year
+27.79%
10 Year
+17.03%
15 Year
+9.64%
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $8.98M | +$1.97M | +28.11% |
| 2024 | $7.01M | +$804,000 | +12.96% |
| 2023 | $6.21M | +$1.03M | +20.00% |
| 2022 | $5.17M | +$676,000 | +15.04% |
| 2021 | $4.50M | +$2.01M | +80.89% |
| 2020 |
TTM Growth
+53.42%
3-Year CAGR
+26.58%
5-Year CAGR
+27.79%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:42:31.537Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| N/A |
| Germany | $286,000 | $519,000 | N/A | N/A | N/A | N/A |
|---|
| GERMANY | N/A | N/A | $866,000 | $896,000 | $926,000 | $1M |
|---|
| Italy | N/A | $415,000 | N/A | N/A | N/A | N/A |
|---|
| ITALY | N/A | N/A | $970,000 | $1M | $1M | $1M |
|---|
| Middle East | $792,000 | $94,000 | N/A | N/A | N/A | N/A |
|---|
| Other | N/A | $818,000 | N/A | N/A | N/A | N/A |
|---|
| Other Countries | $1M | N/A | $3M | $3M | $4M | $4M |
|---|
| POLAND | N/A | N/A | N/A | N/A | N/A | $1M |
|---|
| Russia | $3,000 | N/A | N/A | N/A | N/A | N/A |
|---|
| Spain | $242,000 | N/A | N/A | N/A | N/A | N/A |
|---|
| UNITED STATES | N/A | N/A | N/A | N/A | N/A | $1M |
|---|
| $2.48M |
| ($1.24M) |
| (33.22%) |
| 2019 | $3.72M | +$120,000 | +3.33% |
| 2018 | $3.60M | +$840,000 | +30.42% |
| 2017 | $2.76M | +$867,000 | +45.78% |
| 2016 | $1.89M | ($416,000) | (18.01%) |
